Low intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial
Brain Stimulation · 2025-01 · 18 (1) · 179-187
DOI: 10.1016/j.brs.2025.01.015 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Brain Stimulation, 2025-01. Verfasst von Ziping Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Duke University School of Medicine, USA; Department of Biomedical Engineering, Duke University, USA. Hauptthemen laut MEDLINE: Stroke, Stroke Rehabilitation, Motor Cortex, Ultrasonic Therapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association Inc.
Themen: Schlaganfall
Abstract (Originalsprache)
OBJECTIVE: We aimed to determine the maximum safe spatial-peak pulse-average intensity (ISPPA) of low-intensity focused ultrasound stimulation (LIFUS) in stroke patients and explore its effect on motor learning and corticospinal excitability. METHODS: We adopted the classic 3 + 3 design to escalate ISPPA (estimated in-vivo transcranial value) from 0, 1, 2, 4, 6, to 8 W/cm2. Stopping rules were pre-defined: 2nd-degree scalp burn, clinical seizure, new lesion on diffusion-weighted imaging or major reduction in apparent diffusion coefficient, and participant discontinuation due to any reason. We applied 12-min LIFUS over the ipsilesional motor cortex while participants were concurrently practicing 3 blocks of a motor sequence learning (MSL) task using the affected hand. We measured MSL (response time) and corticospinal excitability (motor evoked potential) pre- and post-stimulation and compared MSL and corticospinal excitability between the LOW (0, 1, and 2 W/cm2) and HIGH (4, 6, and 8 W/cm2) groups. RESULTS: ISPPA was escalated to 8 W/cm2 with 18 stroke participants without meeting the stopping rules. Compared to the LOW, more participants in the HIGH performed better on MSL (6/9 vs. 0/9, p = 0.009) and showed a sign of greater corticospinal excitability (7/9 vs. 5/9, p = 0.62). INTERPRETATION: Our phase-I safety study suggests that one session of LIFUS up to 8 W/cm2 ISPPA is safe and feasible in stroke patients, and LIFUS at high intensity induces positive changes in both MSL and corticospinal excitability. The next logical step is to conduct a phase-II trial testing the efficacy of LIFUS and continuously monitoring its safety profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Duke University School of Medicine, USA; Department of Biomedical Engineering, Duke University, USA.
- Department of Neurology, Duke University School of Medicine, USA.
- Department of Mechanical and Aerospace Engineering, North Carolina State University, USA.
- Department of Physical Medicine and Rehabilitation, Penn State College of Medicine, USA; Department of Kinesiology, Pennsylvania State University, USA.
- Duke Brain Imaging and Analysis Center, Duke University School of Medicine, USA.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, USA.
Förderung
- American Heart Association Inc
Zitieren
APA
Huang, Z., Charalambous, C. C., Chen, M., Kim, T., Sokhadze, E., Song, A., Jung, S. H., Shekhar, S., Feld, J. A., Jiang, X., & Feng, W. (2025). Low intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial. Brain Stimulation, 18(1), 179-187. https://doi.org/10.1016/j.brs.2025.01.015
Vancouver
Huang Z, Charalambous CC, Chen M, Kim T, Sokhadze E, Song A, et al. Low intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial. Brain Stimulation. 2025;18(1):179-187. doi:10.1016/j.brs.2025.01.015
BibTeX
@article{Huang2025,
author = {Huang, Ziping and Charalambous, Charalambos C and Chen, Mengyue and Kim, Taewon and Sokhadze, Estate and Song, Allen and Jung, Sin-Ho and Shekhar, Shashank and Feld, Jody A and Jiang, Xiaoning and Feng, Wuwei},
title = {Low intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial},
journal = {Brain Stimulation},
year = {2025},
volume = {18},
number = {1},
pages = {179--187},
doi = {10.1016/j.brs.2025.01.015}
}
EUVIMED